*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Pharmacological evaluation of the efficacy of metabolic drugs for acute biliary pancreatitis

Author: TETIANA POTAPOVA*, OLENA KOVALENKO, ANNA PROKHACH, VALENTYNA OPRYSHKO, HANNA PELESHENKO, DMYTRO BAS
Abstract: Rate of acute pancreatitis is up to 40 cases per year per 100,000 adults, while about 10-15% of patients have severe forms of this disease, among which the mortality rate reaches 80%. Aim: to experimentally evaluate the pharmacological efficacy of the combined use of drugs (immunomodulators, antioxidants and membrane protectors) in acute biliary pancreatitis with a high degree of severity.A laboratory rat population was used for the study. 210 animals were divided into 3 groups. Group 1 did not receive any drugs, group 2 received a combination of ferrovir, mexidol and phosphogliv, and group 3 received a combination of polyoxidonium and Essentiale N. Before and after the administration of drugs combination, the indicators of the immunological status and parameters of the oxidative system were evaluated.Combination of ferrovir, mexidol and phosphogliv with mild pancreatitis corrects 12.0% and normalizes 75% of the studied laboratory immune and oxidative indices, respectively. With a moderate degree of pancreatitis, these indicators were 19.2% and 45%, and with a severe degree, corresponding to the control values. For group 3, drug combination leads to normal laboratory values of immune and oxidative status in mild pancreatitis, with moderate severity it normalizes 27% and correlates in 73% of cases, and with severe severe it correlates with all studied results.As established experimentally, mild forms of biliary pancreatitis are completely corrected with different drug combinations. With moderate and severe severity, there are immunometabolic disorders recorded. The combination proposed in this case is neither sufficiently effective nor ineffective.This study has convincingly proved the relevance of drug treatment of mild biliary pancreatitis with drug combination on the example of laboratory animals. At the same time, drug treatment is ineffective for moderate and severe pancreatitis. The study requires the continuation and testing of the resulting drug combination for mild biliary pancrea
Keyword: biliary pancreatitis; ferrovir, mexidol, phosphogliv, polyoxidonium, Essentiale N, combination
DOI: https://doi.org/10.31838/ijpr/2019.11.01.305
Download: Request For Article
 
Clients

Clients

Clients

Clients

Clients
ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free